Sofinnova Investments, Inc. Clovis Oncology, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $492,440 - $1.92 Million	-125,303 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $751,537 - $1.51 Million	58,668 Added 88.04%	125,303 $1.86 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $3.91 Million - $6.7 Million	-221,134 Reduced 76.84%	66,635 $1.65 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $3.35 Million - $9.4 Million	287,769 New	287,769 $5.17 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.